ProMIS Neurosciences Inc. (NASDAQ: PMN) will consolidate its outstanding common shares in a one‑for‑twenty‑five reverse split that will take effect at 12:01 a.m. Eastern Time on November 28 2025. The transaction will reduce the number of shares from roughly 53.8 million to about 2.15 million, keeping the company’s market capitalization unchanged while raising the per‑share price above the $1.00 minimum required by Nasdaq.
Continue reading for full analysis...